Standard or custom package
excellent quality and reliable supplier
*The following content is generated by AI and is for reference only.
Overview
Dabrafenib is a selective BRAF kinase inhibitor used in oncology. Its synthesis involves advanced organic coupling with purity exceeding 98%. Molecular Formula: C21H17ClF3N5O; CAS No.: 871700-43-3.
Application
- Oncology Manufacturing: Active pharmaceutical ingredient (API) for metastatic melanoma treatment.
- Research & Development: Targeted therapy studies for BRAF V600E mutation-positive tumors.
- Formulation Production: Component in combination therapies with MEK inhibitors.
Precautions
Strictly store below 25°C in dry, dark conditions. Clinical use requires monitoring for fever and pyrexia. Handling mandates PPE to prevent dermal exposure during bulk processing.